Metabolic Endocrinology and Growth Hormone in Adults

NCT01080755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2014-03-11

No results posted yet for this study

Summary

This is a multicentric, longitudinal, observational study with the prospective follow-up of Adult subjects with Growth Hormone Deficiency (AGHD) being treated with Saizen, every six months in the first year and then annually. At the request of health authorities, the sponsor has arranged for the follow-up of prescriptions and treated subjects within the scope of this indication.

Conditions

  • Adult Growth Hormone Deficiency

Sponsors & Collaborators

  • Merck KGaA, Darmstadt, Germany

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2012-09-30
Completion
2012-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01080755 on ClinicalTrials.gov